drugset / Trial / NCT02217787

Food Effect Study for PF-06372865

NCT02217787

Phase 1 Completed 12 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

This study has been designed to investigate the effect of high fat food on the pharmacokinetics of PF-06372865 when administered to healthy subjects as single oral doses.

Timeline

Start
2014-09
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Darigabat Small molecule 7.5 mg Oral

Indications

No indication recorded.